# Anesthetic Effect Duration Assessment

> **NCT01545765** · PHASE4 · COMPLETED · sponsor: **Galderma R&D** · enrollment: 30 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** Lidocaine 7% + Tetracaine 7% cream

## Key facts

- **NCT ID:** NCT01545765
- **Lead sponsor:** Galderma R&D
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-05
- **Primary completion:** 2012-05
- **Final completion:** 2012-05
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2021-09-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01545765

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01545765, "Anesthetic Effect Duration Assessment". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01545765. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*